Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Buprenorphine/naloxone
Locations
1
United States
UHS Addiction Medicine
Binghamton, New York, United States
Start Date
July 1, 2022
Primary Completion Date
June 30, 2024
Completion Date
December 31, 2024
Last Updated
May 26, 2023
NCT06651177
NCT06843213
NCT05995886
NCT07044466
NCT07350148
NCT06585709
Lead Sponsor
United Health Services Hospitals, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions